Literature DB >> 7989872

REPR and complementation factor(s) interact to modulate rat apolipoprotein B mRNA editing in response to alterations in cellular cholesterol flux.

Y Inui1, F Giannoni, T Funahashi, N O Davidson.   

Abstract

Apolipoprotein B (apoB) mRNA editing is a post-transcriptional cytidine deamination involving several protein factor(s), one of which has recently been cloned. We have examined the effects of alterations in cellular cholesterol flux in the rat liver and small intestine as a means of dissecting the physiologic mechanisms regulating apoB mRNA editing, both in vivo and in isolated S-100 extracts. Hepatic cholesteryl ester accumulation was produced by feeding rats a high cholesterol diet, alone, or in combination with either ethinyl estradiol treatment, or after induction of hypothyroidism. Endogenous hepatic apoB mRNA editing decreased in parallel with the increase in cellular cholesteryl ester content (r = -0.948, P < 0.001). None of these conditions altered endogenous intestinal apoB mRNA editing. Hepatic S-100 extracts demonstrated decreased in vitro apoB RNA editing activity, in parallel with the changes observed in vivo. By contrast, the activity of intestinal S-100 extracts demonstrated a paradoxical increase in hypothyroid rats and a similar, paradoxical decrease in hyperthyroid rats, when compared to controls. Hepatic REPR mRNA, quantitated by RNase protection assay, showed a 25-50% decrease in cholesterol-fed rats. The editing activity of hepatic S-100 extracts prepared from cholesterol-fed, hypothyroid rats was restored to control levels with REPR supplementation but not with chicken intestinal S-100 extracts, suggesting that changes in REPR, but not complementation activity, may play a critical role in the regulation of apoB mRNA editing in rat liver. By contrast, the editing activity of intestinal S-100 extracts prepared from hyperthyroid animals was unaltered by supplementation with REPR, but was restored to control levels after the addition of chicken intestinal S-100 extracts. Taken together, the data suggest that tissue-specific factors regulate apoB mRNA editing in the rat and that the complex interplay of REPR and complementation factor(s) may be modulated in response to alterations in cholesterol flux, in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989872

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  Acute modulation of the extent of apoB mRNA editing and the relative rates of syntheses of apoB48 and apoB100 in cultured rat hepatocytes by osmotic and other stress stimuli.

Authors:  A McCahill; D J Lankester; B S Park; N T Price; V A Zammit
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

2.  A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors.

Authors:  A J Cappione; B L French; G R Skuse
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

3.  Multiple protein domains determine the cell type-specific nuclear distribution of the catalytic subunit required for apolipoprotein B mRNA editing.

Authors:  Y Yang; Y Yang; H C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.

Authors:  Z Chen; T L Eggerman; A P Patterson
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

5.  Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.

Authors:  M P Sowden; M J Eagleton; H C Smith
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

6.  Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.

Authors:  M B Elam; M A von Wronski; L Cagen; F Thorngate; P Kumar; M Heimberg; H G Wilcox
Journal:  Lipids       Date:  1999-08       Impact factor: 1.880

7.  Commitment of apolipoprotein B RNA to the splicing pathway regulates cytidine-to-uridine editing-site utilization.

Authors:  M P Sowden; H C Smith
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

8.  An auxiliary factor containing a 240-kDa protein complex is involved in apolipoprotein B RNA editing.

Authors:  D Schock; S R Kuo; M F Steinburg; M Bolognino; J D Sparks; C E Sparks; H C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

9.  Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.

Authors:  M Rudling; H Olivecrona; G Eggertsen; B Angelin
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

10.  The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.

Authors:  G R Skuse; A J Cappione; M Sowden; L J Metheny; H C Smith
Journal:  Nucleic Acids Res       Date:  1996-02-01       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.